Visceral pain is defined as an internal pain caused due to inflammation of internal organs such as uterus, stomach, rectum, and bladder. This inflammation arises owing to several factors such as infection, trauma, or any injury outside or inside of the internal organs. The visceral pain caused by this varies in strength from being sharp, constant or sometimes very deep pain such as squeezing out of the body.
The Global Visceral Pain Treatment Market is estimated to be valued at US$ 11,673.8 million in 2021 and is expected to rise at a CAGR of +5% during the forecast period 2021-2027.
Request a sample copy of this report @ Click here: –
Visceral pain associated with ailments such as inflammatory bowel diseases, gallstones, acute pancreatitis, acute appendicitis, and diverticulitis are the most common reasons for visits to outpatient and inpatient gastrointestinal (GI) clinics. High prevalence and increase in incidence of target diseases boost market growth. Inflammatory bowel diseases are most common in developed countries compared to developing countries. These diseases affect men and women alike and mostly affect people aged between 15 and 30.
In terms of revenue, North America dominated the global visceral pain treatment market in 2019 due to increase in awareness about visceral pain treatment and rise in government initiatives. Additionally, surge in investment in research & development by various pharmaceutical companies drives the market in North America. Neomed Management AS, Arena Pharmaceuticals, Inc., and Anavex Life Sciences Corp. are the major companies having drugs in the visceral pain therapeutic pipeline. Increase in incidence of diseases is also a major factor propelling the market in the region.
Major Key Players are Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.
The report includes company profiling of almost all important players of the global Visceral Pain Treatment market. The company profiling section offers valuable analysis on strengths and weaknesses, business developments, recent advancements, mergers and acquisitions, expansion plans, global footprint, market presence, and product portfolios of leading market players.
The report also provides accurate estimations about the CAGR, revenue, production, sales, and other calculations for the global Visceral Pain Treatment market. Each regional market is extensively studied in the report to explain why some regions are progressing at a high rate while others at a low rate. We have also provided Porter’s Five Forces and PESTLE analysis for a deeper study on the global Visceral Pain Treatment market.
Visceral Pain Treatment Market Segmentation
By Drug Type:
- Pain modifiers:
- Tricyclic Anticonvulsant,
- Tricyclic Antidepressants.
- Chronic prostatitis,
- Interstitial cystitis,
- Crohn’s Disease,
- Irritable bowel syndrome.
By Distribution Channel:
- Hospital Pharmacy,
- Retail Pharmacy,
- Online Channels
Inquire Before Buying This Research Report: –
- North America(The United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, and Italy)
- Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)
- South America(Brazil, Argentina, Colombia, etc.)
- The Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
Detailed TOC of Global Visceral Pain Treatment Market Research Report-
– Visceral Pain Treatment Market Introduction and Market Overview
– Visceral Pain Treatment Market, by Application
– Visceral Pain Treatment Market Industry Chain Analysis
– Visceral Pain Treatment Market, by Type
– Industry Manufacture, Consumption, Export, Import by Regions
– Industry Value ($) by Region
– Global Visceral Pain Treatment Market Status and SWOT Analysis by Regions
– Major Region of Visceral Pain Treatment Market
- i) Global Visceral Pain Treatment Market Sales
- ii) Global Visceral Pain Treatment Market Revenue & market share
– Major Companies List
Report Consultant is a prime destination for your business aptitude and analytical solutions because we provide qualitative and quantitative sources of information that are proficient to give one-stop solutions. We skillfully syndicate qualitative and quantitative research in exact proportions to have the best report, which not only gives the most recent insights but also assists you to grow.
Contact No: +81-368444299